TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -2 | 0 | -2 | -7 | 6 | 90 | 17 |
| S | %wins | 100 | 100 | 100 | 100 | 0 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/7/06 17:46 | 12/5/06 | AUXL | Auxilium Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Perseus Soros Biopharmaceutical Fund LP | NY | T | S | -24,000 | 16.00 | 8 | -1,500 | -39 | 2,377 | D | 73 | 163 | 79 | 80 | 30 | -6 | -2 | -4 | -2 | 0 | -2 | -7 | 6 | 90 | ||
12/15/05 20:26 | 12/14/05 | ARXT | Adams Respiratory Therapeutics, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Perseus Soros Biopharmaceutical Fund LP | NY | T | S | -75,051 | 43.75 | 0 | -1,715 | -34 | 3,373 | D | |||||||||||||||
7/28/05 16:55 | 7/26/05 | ARXT | Adams Respiratory Therapeutics, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Perseus Soros Biopharmaceutical Fund LP | NY | T | S.d | -25,438 | 15.81 | 0 | -1,609 | -14 | 10,266 | D | |||||||||||||||
2/17/05 19:34 | 2/15/05 | BTRX | Barrier Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Perseus Soros Biopharmaceutical Fund LP | NY | H | See foot | S | -8,385 | 19.50 | 0 | -430 | -16 | 2,325 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |